Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | E | CTAS |
|---|---|---|
| Price | $55.04 | $197.68 |
| Change today | ▲ 0.38% | ▲ 2.97% |
| Market cap | $79.01B | $78.98B |
| Return, 3 months | +17.6% | +17.2% |
| Return, year to date | +48.4% | +5.9% |
| Return, 1 year | +60.8% | -1.2% |
| P/E (TTM) | 14.4 | 39.0 |
| P/B | 1.3 | 15.2 |
| P/E percentile vs own 5y | 56th | 44th |
| Dividend yield | 4.37% | 0.95% |
| Revenue growth (YoY, latest qtr) | +32.1% | +8.9% |
| Net profit growth (YoY) | +501.8% | +14.0% |
| Gross margin | 11.7% | 50.7% |
| Operating margin | 8.0% | 23.3% |
| Net margin | 5.7% | 17.7% |
| Return on equity | 10.0% | 40.6% |
| Analyst target vs. price | – | +11.8% |
| Analyst buy share | 0% | 75% |
| RSI (14) | 52 | 46 |
| 30-day volatility | 26.9% | 14.8% |
| Max drawdown, 1 year | -20.0% | -20.0% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.